Archford Capital Strategies’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$376K Sell
1,038
-16
-2% -$5.48K 0.04% 280
2026
Q1
$371K Sell
1,054
-311
-23% -$111K 0.04% 260
2025
Q4
$447K Hold
1,365
0.05% 241
2025
Q3
$385K Sell
1,365
-831
-38% -$241K 0.05% 249
2025
Q2
$613K Sell
2,196
-619
-22% -$175K 0.08% 200
2025
Q1
$877K Sell
2,815
-3,019
-52% -$891K 0.13% 158
2024
Q4
$1.52M Buy
5,834
+71
+1% +$21.1K 0.23% 105
2024
Q3
$1.87M Sell
5,763
-529
-8% -$173K 0.28% 89
2024
Q2
$1.97M Buy
6,292
+66
+1% +$19.4K 0.32% 78
2024
Q1
$1.77M Buy
6,226
+334
+6% +$97.7K 0.3% 89
2023
Q4
$1.7M Buy
5,892
+606
+11% +$165K 0.31% 88
2023
Q3
$1.42M Sell
5,286
-308
-6% -$76.9K 0.28% 90
2023
Q2
$1.32M Buy
5,594
+140
+3% +$32.5K 0.25% 94
2023
Q1
$1.38M Buy
5,454
+371
+7% +$91.1K 0.29% 83
2022
Q4
$1.34M Buy
5,083
+736
+17% +$197K 0.31% 81
2022
Q3
$980K Buy
4,347
+387
+10% +$93.8K 0.25% 101
2022
Q2
$963K Buy
3,960
+299
+8% +$73.3K 0.24% 100
2022
Q1
$895K Buy
3,661
+271
+8% +$62.3K 0.2% 125
2021
Q4
$763K Buy
3,390
+132
+4% +$27.9K 0.17% 142
2021
Q3
$693K Buy
3,258
+156
+5% +$35.9K 0.16% 149
2021
Q2
$756K Buy
3,102
+54
+2% +$13.3K 0.19% 139
2021
Q1
$778K Sell
3,048
-9,319
-75% -$2.22M 0.21% 130
2020
Q4
$2.95M Buy
12,367
+73
+0.6% +$16.8K 0.68% 34
2020
Q3
$3.13M Sell
12,294
-10
-0.1% -$2.48K 0.84% 26
2020
Q2
$2.9M Buy
12,304
+198
+2% +$45.2K 0.86% 22
2020
Q1
$2.45M Sell
12,106
-209
-2% -$45.7K 0.96% 23
2019
Q4
$2.97M Sell
12,315
-715
-5% -$158K 1.02% 19
2019
Q3
$2.52M Sell
13,030
-30
-0.2% -$5.76K 0.94% 22
2019
Q2
$2.41M Buy
13,060
+289
+2% +$51.7K 0.88% 23
2019
Q1
$2.43M Sell
12,771
-121
-0.9% -$23.1K 0.89% 24
2018
Q4
$2.51M Buy
12,892
+308
+2% +$60.1K 1.01% 22
2018
Q3
$2.61M Sell
12,584
-703
-5% -$139K 0.95% 19
2018
Q2
$2.45M Buy
13,287
+1,049
+9% +$186K 0.86% 20
2018
Q1
$2.13M Buy
12,238
+19
+0.2% +$3.49K 0.89% 38
2017
Q4
$2.13M Buy
12,219
+528
+5% +$93.4K 0.79% 39
2017
Q3
$2.18M Buy
11,691
+2,567
+28% +$455K 0.82% 37
2017
Q2
$1.57M Buy
9,124
+1,056
+13% +$172K 0.62% 50
2017
Q1
$1.33M Buy
+8,068
New +$1.34M 0.5% 60
2016
Q4
Sell
-3,957
Closed -$660K 628
2016
Q3
$660K Buy
3,957
+3,938
+20,726% +$666K 0.27% 124
2016
Q2
$3K Buy
+19
New +$2.95K ﹤0.01% 562
2016
Q1
Sell
-19
Closed -$4K 192
2015
Q4
$4K Hold
19
﹤0.01% 585
2015
Q3
$3K Hold
19
﹤0.01% 526
2015
Q2
$3K Hold
19
﹤0.01% 415
2015
Q1
$3.04K Hold
19
﹤0.01% 446
2014
Q4
$3K Hold
19
﹤0.01% 425
2014
Q3
$3K Hold
19
﹤0.01% 429
2014
Q2
$2.25K Hold
19
﹤0.01% 663
2014
Q1
$2.34K Buy
+19
New +$2.3K ﹤0.01% 632

Other funds holding AMGN

Archford Capital Strategies's AMGN Position: Q2 2026 in Review

Archford Capital Strategies reduced its Amgen (AMGN) stake by 1.5% in Q2 2026, selling an estimated $5.48K and leaving 1,038 shares worth $376K. The position accounts for 0.04% of the portfolio, ranked #280.

Archford Capital Strategies first reported a position in AMGN in Q1 2014 and has held it in 48 quarters since. The position peaked at $3.13M in Q3 2020. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Archford Capital Strategies held 1,038 shares of Amgen worth $376K as of Q2 2026.
  • Archford Capital Strategies sold 16 Amgen shares in Q2 2026, an estimated $5.48K.
  • Amgen made up 0.04% of Archford Capital Strategies's portfolio in Q2 2026, its #280 holding.
  • Archford Capital Strategies first reported a position in Amgen in Q1 2014 and has held it in 48 quarters since.
  • Archford Capital Strategies's Amgen position peaked at $3.13M in Q3 2020.
  • 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Archford Capital Strategies's 13F filing for Q2 2026, filed 17 Jul 2026.